Steward Partners Investment Advisory, LLC Bridge Bio Pharma, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 1,022 shares of BBIO stock, worth $36,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,022
Previous 550
85.82%
Holding current value
$36,679
Previous $14,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
322Shares Held
177MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$907 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$902 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$541 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$447 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$222 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.32B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...